< previous page page_295 next page >

Page 295
11
Clinical Pharmacology in Drug Development: A View to Future Effectiveness
J. Robert Powell, Alan Bye, and Paul D. Rubin
Glaxo-Wellcome Inc.
Research Triangle Park, North Carolina
6fb6ffc4153cdc534470145c4eef46f0.gif
I. Introduction
296
6fb6ffc4153cdc534470145c4eef46f0.gif
II. Current Environment
297
6fb6ffc4153cdc534470145c4eef46f0.gif
III. The Challenge
298
6fb6ffc4153cdc534470145c4eef46f0.gif
IV. Core Competencies
298
6fb6ffc4153cdc534470145c4eef46f0.gif
V. Applications of Science To Drug Development
299
6fb6ffc4153cdc534470145c4eef46f0.gif
VI. Current and Future Needs
308
6fb6ffc4153cdc534470145c4eef46f0.gif
VII. Management/Organization
308
6fb6ffc4153cdc534470145c4eef46f0.gif
VIII. Science
312
6fb6ffc4153cdc534470145c4eef46f0.gif
IX. People
312
6fb6ffc4153cdc534470145c4eef46f0.gif
X. Conclusion
313
6fb6ffc4153cdc534470145c4eef46f0.gif
References
314

 
< previous page page_295 next page >